文献速递物质与行为成瘾

戒酒期酒精依赖者口服右苯丙胺后内源性阿片释放减弱

Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.
PubMed 文献 · Mol Psychiatry · 2018-06-25

研究采用[11C]卡芬太尼PET显像,比较13名戒酒男性酒精依赖者与15名对照者在口服0.5 mg/kg右苯丙胺前后μ阿片受体可用性与内源性阿片释放。结果显示酒精依赖者在10个感兴趣区中的5个(包括岛叶、额叶和壳核)右苯丙胺诱导的阿片释放显著减弱,但任何脑区μ阿片受体可用性均未显著高于对照。作者认为这种阿片张力失调可能共同见于行为成瘾与物质成瘾。

要点

  • 酒精依赖者部分脑区右苯丙胺诱导的内源性阿片释放显著减弱。
  • 酒精依赖者各脑区μ阿片受体可用性未显著高于健康对照。
  • 该释放减弱模式与既往赌博障碍研究结果相似。

核心结论

  • 戒酒期酒精依赖男性在岛叶、额叶和壳核等5个感兴趣区存在右苯丙胺诱导的内源性阿片释放减弱,但μ阿片受体可用性未显著升高。
  • 作者认为阿片张力失调可能共同见于行为成瘾与物质成瘾。

研究设计与样本

  • 研究纳入13名戒酒男性酒精依赖者与15名对照者,均接受两次[11C]卡芬太尼PET扫描。
  • 两次扫描分别在口服0.5 mg/kg右苯丙胺前及服药3小时后进行,以测量基线μ阿片受体可用性与内源性阿片释放。

主要发现

  • 在10个感兴趣区中的5个,包括岛叶、额叶和壳核,酒精依赖者的右苯丙胺诱导阿片释放较对照显著减弱。
  • 酒精依赖者与健康对照在任何脑区的μ阿片受体可用性均无显著差异。

临床怎么用

  • 结果提示阿片张力失调可能是酒精依赖的奖励缺陷机制之一,支持阿片拮抗剂干预的机制假设。
  • 由于阿片拮抗剂并非对所有酒精依赖者有效,评估个体阿片系统状态可能有助于理解疗效差异。

局限性

  • 样本仅限男性且样本量小(13例酒精依赖者、15名对照)。
  • 原文摘要未报告更多局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Addiction has been proposed as a 'reward deficient' state, which is compensated for with substance use. There is growing evidence of dysregulation in the opioid system, which plays a key role in reward, underpinning addiction. Low levels of endogenous opioids are implicated in vulnerability for developing alcohol dependence (AD) and high mu-opioid receptor (MOR) availability in early abstinence is associated with greater craving. This high MOR availability is proposed to be the target of opioid antagonist medication to prevent relapse. However, changes in endogenous opioid tone in AD are poorly characterised and are important to understand as opioid antagonists do not help everyone with AD. We used [11C]carfentanil, a selective MOR agonist positron emission tomography (PET) radioligand, to investigate endogenous opioid tone in AD for the first time. We recruited 13 abstinent male AD and 15 control participants who underwent two [11C]carfentanil PET scans, one before and one 3 h following a 0.5 mg/kg oral dose of dexamphetamine to measure baseline MOR availability and endogenous opioid release. We found significantly blunted dexamphetamine-induced opioid release in 5 out of 10 regions-of-interest including insula, frontal lobe and putamen in AD compared with controls, but no significantly higher MOR availability AD participants compared with HC in any region. This study is comparable to our previous results of blunted dexamphetamine-induced opioid release in gambling disorder, suggesting that this dysregulation in opioid tone is common to both behavioural and substance addictions.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Turton S, Myers JF, Mick I, et al. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals. Mol Psychiatry. 2018. PMID: 29942043. doi:10.1038/s41380-018-0107-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。